:

Huqun Li1, Wenlong Xie1, Chongshu Wang2

  • 1Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Lupus science & medicine
|January 10, 2025
PubMed
概括

这项研究使用FAERS数据评估了贝利马布的安全性,确定了新的不良事件,如剂量问题和区域差异. 临床医生应监测贝利马布的使用,以获得最佳的患者结果.